Immunogenicity and Safety of Pentaxim in South African Infants

Clinical trial NCT00254969 · COMPLETED

Trial details

NCT number: NCT00254969
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Haemophilus Infections Pertussis Poliomyelitis

Start date: 2005-10-01
Primary completion: 2008-05-01
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.